✦ LIBER ✦

Tolerability of eslicarbazepine acetate as adjunctive therapy of adult patients with partial-onset seizures up to one year of follow-up

✍ Scribed by Elger, C.; Ben-Menachem, E.; Gil-Nagel, A.; Sousa, R.; Gama, H.; Soares-da-Silva, P.

Book ID: 122496244
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 77 KB
Volume: 333
Category: Article
ISSN: 0022-510X
DOI: 10.1016/j.jns.2013.07.158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of eslicarbazepine acetate as a

Efficacy of eslicarbazepine acetate as adjunctive therapy of adult patients with partial-onset seizures up to one year of follow-up

✍ Gil-Nagel, A.; Elger, C.; Ben-Menachem, E.; Sousa, R.; Moreira, J.; Soares-da-Si 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Efficacy and safety of 800 and 1200 mg e

Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures

✍ A. Gil-Nagel; J. Lopes-Lima; L. Almeida; J. Maia; P. Soares-da-Silva; on behalf 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

Long-term safety and efficacy of eslicar

Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: Results of a 1-year open-label extension study

✍ Hufnagel, Andreas; Ben-Menachem, Elinor; Gabbai, Alberto A.; Falcão, Amílcar; Al 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 389 KB

Efficacy and safety of eslicarbazepine a

Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study

✍ Christian Elger; Peter Halász; Joana Maia; Luis Almeida; Patrício Soares-da-Silv 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 337 KB

Adjunctive levetiracetam in patients age

Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: Subpopulation analysis of a prospective, open-label extension study of up to 48 weeks

✍ Jesus Eric Piña-Garza; Jimmy Schiemann-Delgado; Haichen Yang; Benjamin Duncan; J 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Long-term evaluation of the efficacy and

Long-term evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures: a 1-year open follow-up

✍ T. Rentmeester; A. Janssen; J. Hulsman; F. Scholtes; B. van der Kleij; J. Overwe 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 534 KB

The effect and safety of loreclezole were evaluated during a long-term follow-up trial targeting higher plasma concentrations than those of the preceding controlled trial. The result is better than in the double-blind trial, in which loreclezole doses were administered to reach plasma concentrations